Welcome to LookChem.com Sign In|Join Free
  • or
1-(4-Bromo-3-methoxyphenyl)ethanone, a chemical compound with the molecular formula C9H9BrO2, is a ketone featuring a benzene ring substituted with a bromine atom at the 4 position and a methoxy group at the 3 position. 1-(4-BroMo-3-Methoxyphenyl)ethanone is recognized for its role in organic synthesis and pharmaceutical research, where it serves as a versatile building block for the creation of diverse pharmaceuticals and bioactive molecules.

50870-44-5

Post Buying Request

50870-44-5 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

50870-44-5 Usage

Uses

Used in Pharmaceutical Research and Development:
1-(4-Bromo-3-methoxyphenyl)ethanone is utilized as a key intermediate in the synthesis of various pharmaceuticals and bioactive molecules. Its unique structure allows for the development of new drugs with potential therapeutic applications in treating a range of diseases and conditions.
Used in Medicinal Chemistry:
In the field of medicinal chemistry, 1-(4-Bromo-3-methoxyphenyl)ethanone is employed as a valuable component in the design and synthesis of novel drug candidates. Its presence in molecular structures can contribute to the modulation of biological activities, making it a promising agent for the advancement of pharmaceutical therapies.
Used in Agricultural Research and Development:
1-(4-Bromo-3-methoxyphenyl)ethanone may also find applications in the research and development of crop protection products within the agricultural industry. Its chemical properties could be harnessed to create innovative solutions for pest control and crop enhancement, thereby contributing to sustainable agricultural practices.

Check Digit Verification of cas no

The CAS Registry Mumber 50870-44-5 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,0,8,7 and 0 respectively; the second part has 2 digits, 4 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 50870-44:
(7*5)+(6*0)+(5*8)+(4*7)+(3*0)+(2*4)+(1*4)=115
115 % 10 = 5
So 50870-44-5 is a valid CAS Registry Number.

50870-44-5SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 12, 2017

Revision Date: Aug 12, 2017

1.Identification

1.1 GHS Product identifier

Product name 1-(4-bromo-3-methoxyphenyl)ethanone

1.2 Other means of identification

Product number -
Other names 3-methoxy-4-bromoacetophenone

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:50870-44-5 SDS

50870-44-5Relevant academic research and scientific papers

CERAMIDE GALACTOSYLTRANSFERASE INHIBITORS FOR THE TREATMENT OF DISEASE

-

Paragraph 00249; 00250; 00916; 00918; 001235; 001236, (2018/07/29)

Described herein are compounds, methods of making such compounds, pharmaceutical compositions and medicaments containing such compounds, and methods of using such compounds to treat or prevent diseases or disorders associated with the enzyme ceramide galactosyltransferase (CGT), such as, for example, lysosomal storage diseases. Examples of lysosomal storage diseases include, for example, Krabbe disease and Metachromatic Leukodystrophy.

ISOQUINOLINE COMPOUNDS, A PROCESS FOR THEIR PREPARATION, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM

-

Paragraph 0260; 0261; 0262; 0263, (2017/06/12)

A compound of formula (I): wherein the substituents are as defined in the description. Medicinal products containing the same which are useful in treating or preventing pathologies which are the result of activation of the RhoA/ROCK pathway and phosphorylation of the myosin light chain.

Structure-based approach to the development of potent and selective inhibitors of dihydrofolate reductase from Cryptosporidium

Bolstad, David B.,Bolstad, Erin S. D.,Frey, Kathleen M.,Wright, Dennis L.,Anderson, Amy C.

experimental part, p. 6839 - 6852 (2009/11/30)

Cryptosporidiosis is an emerging infectious disease that can be life-threatening in an immune-compromised individual and causes gastrointestinal distress lasting up to 2 weeks in an immune-competent individual. There are few therapeutics available for eff

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 50870-44-5